Importance of presumed germline pathogenic variants and genetic support after tumor-only sequencing

被引：0
|
作者：
Kawamura, Miyuki [1 ]
Matsumoto, Koji [1 ]
Morita, Mitsunori [1 ]
Sakai, Hideki [1 ]
Onoe, Takuma [1 ]
Urakawa, Yusaku [2 ,3 ]
Sugawara, Hiromi [4 ]
Ueno, Sayaka [5 ]
Sudo, Tamotsu [5 ,6 ]
机构：
[1] HCC, Dept Med Oncol, Osaka, Japan
[2] Okayama Univ, Dept Clin Gen Dent & Pharm Sci, Okayama, Japan
[3] Kobe City Med Ctr, Gen Hosp, Dept Med Oncol, Kobe, Hyogo, Japan
[4] HCC, Dept Clin Genet, Osaka, Japan
[5] HCC, Dept Translat Res, Osaka, Japan
[6] HCC, Dept Clin Ctr Canc Genom & Clin Res, Osaka, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J7-2-6
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients
    Yoon, Ju-Yoon
    Roth, Jacquelyn J.
    Rushton, Chase A.
    Morrissette, Jennifer J. D.
    Nathanson, Katherine L.
    Cohen, Roger B.
    Rosenbaum, Jason N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06)
  • [32] Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing-A Quality Assurance Strategy
    Menard, Timothe
    JCO PRECISION ONCOLOGY, 2022, 6
  • [33] Incidence of pathogenic germline variants and presumed germline pathogenic variants in Japanese lung cancer patients using comprehensive genomic profiling tests
    Ueki, Michiko
    Watanabe, Kousuke
    Morishita, Momoko
    Fujii, Koki
    Ikushima, Hiroki
    Isago, Hideaki
    Oda, Katsutoshi
    Kage, Hidenori
    CANCER RESEARCH, 2024, 84 (06)
  • [34] TSomVar: a tumor-only somatic and germline variant identification method with random forest
    Shi, Shuo
    Wang, Qi
    Shang, Yunfei
    Bu, Congfan
    Lu, Mingming
    Jiang, Meiye
    Zhang, Hao
    Yu, Shuhuan
    Zeng, Jingyao
    Zhang, Zaichao
    Du, Zhenglin
    Xiao, Jingfa
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (05)
  • [35] Validating models of imputing germline versus somatic status for variants detected by tumor-only genomic profiling using germline clinical testing data
    Gomy, Israel
    Jalloul, Nahed
    Stokes, Samantha
    Gusev, Alexander
    Ganesan, Shridar
    Garber, Judy
    Khiabanian, Hossein
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups
    Yan W. Asmann
    Kaushal Parikh
    P. Leif Bergsagel
    Haidong Dong
    Alex A. Adjei
    Mitesh J. Borad
    Aaron S. Mansfield
    npj Precision Oncology, 5
  • [37] Assessment of Germline Splice Variants in Tumor Sequencing
    Bogdanova, E.
    Soens, Z.
    Silkov, A.
    Chen, R.
    Edelman, L.
    Funke, B.
    Al-Kateb, H.
    Hantash, F.
    Rossi, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S125 - S125
  • [38] Paired tumor/normal clinical sequencing enables identification of patients with pathogenic germline variants.
    Dimopoulos, Christina N.
    Brierley, Karina
    Gibson, Joanna
    Walther, Zenta
    Llor, Xavier
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Characteristics of presumed germline pathogenic variants found through cancer precision medicine
    Sogawa, Reimi
    Yamamoto, Hideki
    Kochi, Mariko
    Futagawa, Mashu
    Urakawa, Yusaku
    Ennishi, Daisuke
    Tomida, Shuta
    Hirasawa, Akira
    CANCER SCIENCE, 2022, 113 : 370 - 370
  • [40] Germline BAP1 mutations misreported as somatic based on tumor-only testing
    Mohamed H. Abdel-Rahman
    Karan Rai
    Robert Pilarski
    Frederick H. Davidorf
    Colleen M. Cebulla
    Familial Cancer, 2016, 15 : 327 - 330
12345